The FDA approval of belatacept has thus spurred desire for developing a clinically translatable strategy to inhibit the CD154 and CD40 pathway in order to harness this synergy to achieve maximum benefit in clinical application. decade has resulted in substantial
Class IV glucocorticoids (e
Class IV glucocorticoids (e.g., clobetasol) can be applied to the scalp, palms, and soles, whereas in other areas only class II (e.g., methylprednisolone aceponate) and class III (e.g., mometasone furoate) glucocorticoids are recommended. course of the disease, even in lupus